SCHEMBL8670456

SCHEMBL8670456

CN(C(=O)C1CC(S(=O)(=O)c2ccccc2)C(c2ccccc2F)N1c1ccccc1C(CC=O)(NC(N)=O)C(=O)O)c1ccccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8669501 0.86 — —
SCHEMBL8673195 0.86 LMNA (0.35) —
SCHEMBL8671612 0.85 — —
SCHEMBL8670446 0.80 CYP3A4 (0.31) —
SCHEMBL8668725 0.70 MEN1 (0.34) —
SCHEMBL8669486 0.69 — —
SCHEMBL8674681 0.67 SMN1; SMN2 (0.36) —
SCHEMBL8670579 0.66 CTSS (0.37) —
SCHEMBL8672023 0.64 LMNA (0.33) —
SCHEMBL8670326 0.63 AGTR2 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5707991-A TREATMENT OF NERVOUS SYSTEM DISORDERS, PARKINSON'S DISEASE RHONE-POULENC RORER S.A. (FR) 1998-01-13 — — US disclosed
Send feedback